Mustang Bio, Inc.
MBIO
Last
$0.40
Day
-4.1%
1y
-76.4%
5y
-100.0%
52w
-77.5%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0626d
EMA 21
0.48
EMA 50
0.53
EMA 200
1.12
20d high
-25.2%
5y high
-100.0%
5y range
0th
Positions held
Your positionsMBIO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$0.46
Stop
$0.38
Stop distance
5.0%
Target vs last
+15.0%
Fundamentals
| Market cap | $3.16M | Enterprise value | -$11.99M | Trailing P/E | — | Forward P/E | -1.19 |
| PEG | — | Price / book | 0.42 | Beta | 2.09 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -58.1% | ROA | -15.4% | Debt / equity | — |
| Current ratio | 1.97 | Free cash flow | -$4.27M | Analyst recommendation | none | Mean target | — |
| 52w high | $1.81 | 52w low | $0.41 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.1M | -$1.0M | -$0.5M | -$0.5M | -$0.8M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.2M | -$1.1M | -$0.7M | -$0.6M | -$0.9M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$1.9M | -$15.8M | -$51.6M | -$77.5M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$2.4M | -$12.6M | -$50.7M | -$76.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsMBIO · daily-21.5% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin